Vaziyatning og'irligini baholash va bolalarda tanqidiy zarba holatlarida natijalarni bashorat qilish uchun integral usullardan foydalanish
Referat
Xulosa: ushbu maqola shoshilinch tibbiy yordamning kasalxonadan oldingi bosqichida kritik shok holati bo'lgan bolalarning holatini yaxlit baholash va natijalarini bashorat qilish masalalariga bag'ishlangan.
Tadqiqot materiallari va usullari: 895 nafar bolaning kasallik tarixi ma'lumotlari retrospektiv tarzda o'rganilib, ulardan 143 nafar 12 yoshdan 18 yoshgacha bo'lgan, Toshkentda tez tibbiy yordam bilan qabul qilingan bolalar tanlab olindi.
Tadqiqot natijalari: diagnostika samaradorligini aniqlash uchun integral tarozi o'zgaruvchilarining statistik parametrlarining qiyosiy tahlili o'tkazildi. Bemorlarning ahvoli og'irligini baholash uchun integral shkalalar kritik shok holati bo'lgan bemorlarda kasallikning natijasini individual prognoz qilish uchun ham, davolash bosqichlarida intensiv terapiya samaradorligini baholashda ham qo'llanilishi mumkinligi aniqlandi.
Xulosa: integral miqyosda faqat nafas olish, yurak-qon tomir va buyrak tizimlarini balli baholashdan foydalanish tanqidiy shok bilan og'rigan bemorlarda natijaning individual prognozini baholashda amaliy qo'llanilishini topishi mumkin.
Mualliflar haqida
Adabiyotlar ro'yxati
Шарипов А. М., Сафаров З. Ф. Интегральная оценка тяжести состояния и прогнозирование исходов детей с критическими состояниями //Вестник национального детского медицинского центра. – 2022. – №. 2. – С. 95-99.
Сафаров З. Ф. и др. Диагностическая эффективность некоторых параметров центральной гемодинамики у детей при шоке //Вестник науки и образования. – 2019. – №. 9-1. – С. 78-87.
Шарипов А.М., Сафаров З.Ф. Проблемы современной догоспитальной помощи и медицины катастроф // Вестник НДМЦ. 2022. №2.
Safarov Z. F. et al. Diagnostic significance of the Algover index for early recognition of shock in children. Problems of modern science and education. 2019;(5 (138)): 78–84.
Jenilo V.M., Bichkov А.А., Litvinova V.N. Obʼektivizatsiya tyajesti sostoyaniya patsientov. // Metodicheskie rekomendatsii. - RostGMU – 2003. – S.12-25.
Сафаров Зафар Файзуллаевич, Абдуллаев Комилжон Гофуржонович, Шоикрамов Шоильес Шорасулович, Алимов Ахрор Абдурасулович Сравнение результатов разных интегральных оценочных систем для оценки степени тяжести критических состояний у детей // Проблемы Науки. 2018. №7 (127).
Svetuxin А.M., Zvyagin А.А., Slepnev S.Yu. Sistemi obʼektivnoy otsenki tyajesti sostoyaniya bolnix. Chast II // Xirurgiya. -2002.-№10.-S.60-69.
Сафаров З. Ф. и др. Применение шкалы SOFA в прогнозировании исходов критических состояний у детей //Проблемы современной науки и образования. – 2018. – №. 7 (127). – С. 82-90.
Bion J.F. Is the gut responsible for multiple organ failure? // Schweiz. Critical Care., 2014 y.
Сафаров З. Ф. и др. Сравнительный анализ интегральных оценочных систем для прогнозирования исходов критических состояний у детей //Медицина: теория и практика. – 2019. – Т. 4. – С. 498-499.
Рекомендации ESC по лечению пациентов с фибрилляцией предсердий, разработанные совместно с EACTS. Российский кардиологический журнал 2017, 7 (147): 7-86; http://dx.doi.org/10.15829/1560-4071-2017-7-7-86
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal, Volume 37, Issue 38, 7 October 2016, Pages 2893-2962.
Bjorck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke 2013; 44:3103–3108.
Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc 2015;4: e001486.
Chiang CE, Naditch-Brule L, Murin J, et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the reallife global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 2012; 5:632–639.
Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013; 167:1807–1824.
Kannel WB,Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82:2N–9N.
McManus DD, Rienstra M, Benjamin EJ. An update on the prognosis of patients with atrial fibrillation. Circulation 2012;126:e143–146.
Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol 2013; 167:2412–2420.
Oldgren J, Healey JS, Ezekowitz M, et al. RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation 2014;129:1568–1576.
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation:European perspective. Clin Epidemiol 2014;6:213–220.
Kishore A, Vail A, Majid A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke 2014;45:520–526.
Sanna T, Diener HC, Passman RS, et al. CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478–2486.
Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920–2925.
Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154–162.
Ansell J, Hirsh J, Poller L et al. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (suppl.): 204S–33S.
Garcia D, Regan S, Crowther M et al. Warfarin maintece dosing patterns in clinical practice: implications for safer anticoagulation in the eldery population. CHEST 2005; 127: 2049–56.
Navar AM, Kolkailah AA, Overton R er al. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. J Am Heart Assoc. 2022 Nov 15;11(22):e026723. doi: 10.1161/JAHA.122.026723. Epub 2022 Nov 8. PMID: 36346063; PMCID: PMC9750070.